Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Sol

Start price
Target price
Perf. (%)
€17.64
11.07.21
€15.00
11.07.22
19.90%
26.11.21

Could be worthwhile Investment >10% per year
buy
Vapiano SE

Start price
Target price
Perf. (%)
€0.31
11.07.21
€0.75
11.07.22
-67.54%
12.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Some uniques
buy
Northern Data AG

Start price
Target price
Perf. (%)
€77.30
11.07.21
€180.00
11.07.22
26.78%
18.11.21

Could be worthwhile Investment >10% per year
Undervalued
Standard Investments for future growth
Normal challenges to pay loans and raise capital
buy
Celtic

Start price
Target price
Perf. (%)
€1.27
11.07.21
€2.25
11.07.22
0.79%
12.07.22

Strong uniques
Stable Large shareholder and/or long term investor
Well known brand
Significant cyclical dependencies
Meta Material Inc.

Start price
Target price
Perf. (%)
€4.20
11.07.21
-
11.07.22
-76.45%
12.07.22

Probably not worthwhile Investment
buy
TAAT Global Alternatives Inc.

Start price
Target price
Perf. (%)
€2.10
11.07.21
€220.00
11.07.22
-57.00%
12.07.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
Undervalued
buy
Ordina NV

Start price
Target price
Perf. (%)
€4.09
10.07.21
-
10.07.22
15.79%
11.07.22

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Netlist Inc.

Start price
Target price
Perf. (%)
€5.19
10.07.21
-
10.07.22
35.26%
26.07.21

Probably not worthwhile Investment
CareCloud Inc.

Start price
Target price
Perf. (%)
€6.85
10.07.21
€3.20
10.07.22
-46.86%
11.07.22

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Adler Real Estate AG

Start price
Target price
Perf. (%)
€12.02
10.07.21
€6.00
10.07.22
-39.77%
11.01.22

Low dividend yield expected
negative Cash Flow expected
Few uniques
Dependend from some customers or products
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€14.32
10.07.21
€20.00
10.07.22
-12.71%
30.07.21

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
buy
Powercell Sweden AB

Start price
Target price
Perf. (%)
€20.25
10.07.21
-
10.07.22
17.23%
18.11.21

Below average Marketposition
Business model of the past or high risk
Risky Investment
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€38.01
10.07.21
€5.00
10.07.22
-62.18%
11.07.22

overvalued
Low dividend yield expected
Few uniques
Dependend from some customers or products
buy
Bilia AB

Start price
Target price
Perf. (%)
€18.66
10.07.21
-
10.07.22
-40.78%
02.03.22

buy
North American Energy Partners Inc.

Start price
Target price
Perf. (%)
€12.40
10.07.21
-
10.07.22
8.87%
02.03.22

Sequential Brands Group Inc.

Start price
Target price
Perf. (%)
€14.40
09.07.21
-
09.07.22
-20.14%
11.07.21

Risky Investment
buy
Paragon ID

Start price
Target price
Perf. (%)
€29.70
09.07.21
€35.00
09.07.22
-12.46%
10.07.22

Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€76.10
09.07.21
-
09.07.22
-25.49%
05.12.21

Aadi Bioscience Inc.

Start price
Target price
Perf. (%)
€36.00
08.07.21
-
08.07.22
-17.29%
12.07.21

Risky Investment
Exela Technologies Inc.

Start price
Target price
Perf. (%)
€12,240
08.07.21
-
08.07.22
-15.69%
12.07.21

Risky Investment
buy
The Exone Company

Start price
Target price
Perf. (%)
€15.59
08.07.21
-
08.07.22
49.71%
16.11.21

Powercell Sweden AB

Start price
Target price
Perf. (%)
€21.09
08.07.21
-
29.06.22
-39.64%
30.06.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Süss MicroTec SE

Start price
Target price
Perf. (%)
€26.90
08.07.21
-
08.07.22
-50.48%
08.07.22